After a string of discouraging clinical trial results and slow sales, Abbott Laboratories Inc. is pulling the plug on the embattled Absorb bioabsorbable coronary stent.
"Due to low commercial sales, Abbott will stop selling the first-generation bioresorbable Absorb coronary stent," the company said in a Sept. 8 statement
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?